Rhoen Klinikum AG
XMUN:RHK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Rhoen Klinikum AG
XMUN:RHK
|
DE |
|
C
|
CME Group Inc
XBER:MX4A
|
US |
|
Bioporto A/S
F:2P4
|
DK |
|
T
|
Teradyne Inc
XMUN:TEY
|
US |
Wall St Price Targets
RHK Price Targets Summary
Rhoen Klinikum AG
According to Wall Street analysts, the average 1-year price target for RHK is 14.81 EUR with a low forecast of 12.94 EUR and a high forecast of 17.22 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RHK's stock price target?
Price Target
14.81
EUR
According to Wall Street analysts, the average 1-year price target for RHK is 14.81 EUR with a low forecast of 12.94 EUR and a high forecast of 17.22 EUR.
What is the Revenue forecast for Rhoen Klinikum AG?
Projected CAGR
5%
Over the last 14 years, the compound annual growth rate for Revenue has been -3%. The projected CAGR for the next 3 years is 5%.
What is the Gross Profit forecast for Rhoen Klinikum AG?
Projected CAGR
-4%
Over the last 14 years, the compound annual growth rate for Gross Profit has been -4%. The projected CAGR for the next 5 years is -4%.
What is the Operating Income forecast for Rhoen Klinikum AG?
Projected CAGR
24%
Over the last 14 years, the compound annual growth rate for Operating Income has been -11%. The projected CAGR for the next 3 years is 24%.
What is the Pre-Tax Income forecast for Rhoen Klinikum AG?
Projected CAGR
19%
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been -10%. The projected CAGR for the next 3 years is 19%.
What is the Net Income forecast for Rhoen Klinikum AG?
Projected CAGR
20%
Over the last 14 years, the compound annual growth rate for Net Income has been -10%. The projected CAGR for the next 3 years is 20%.
